Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages.

Taguchi A, Nagasaka K, Plessy C, Nakamura H, Kawata Y, Kato S, Hashimoto K, Nagamatsu T, Oda K, Kukimoto I, Kawana K, Carninci P, Osuga Y, Fujii T.

Sci Rep. 2020 Oct 22;10(1):17991. doi:10.1038/s41598-020-75133-2

Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages.

nanoCAGE in HPV patient samples.

Posted
NanoCAGE-XL and CapFilter: an approach to genome wide identification of high confidence transcription start sites.

BMC Genomics. 2015 Aug 13;16(1):597. doi:10.1186/s12864-015-1670-6

Cumbie JS, Ivanchenko MG, Megraw M.

NanoCAGE-XL and CapFilter: an approach to genome wide identification of high confidence transcription start sites.

Uses the average G-addition per cluster as a threshold. Notes that G-addition is higher when the riboguanosine linker is preceded by AT-rich sequences.